Leiden, The Netherlands, March 5, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) today announced that theCompany will host a conference call and live audio webcast onTuesday, March 18, 2014 8:00am Eastern Time (1:00pm CentralEuropean Time) to report its full year 2013 financial results andprovide a corporate update. In order to participate in the conference call, please dial1-877-407-9170 (US Domestic toll-free). International dial-innumbers and an audio webcast can be accessed under "Events &Presentations" through the Investors & Media section of theProsensa corporate website at www.prosensa.com. About Prosensa Holding N.V. Prosensa (NASDAQ: RNA) is a Dutch biotechnology company engagedin the discovery and development of RNA-modulating therapeutics forthe treatment of genetic disorders. Its primary focus is on rareneuromuscular and neurodegenerative disorders with a large unmetmedical need, including Duchenne muscular dystrophy, myotonicdystrophy and Huntington's disease. For more information, visit www.prosensa.com.
CONTACT: Prosensa Holding N.V. Celia Economides, Senior Director IR & Corporate Communications Phone: +1 917 975 1983 Email: email@example.com